Market Analysis and Insights
The global Botanical Drug market is projected to grow from US$ 38164 million in 2023 to US$ 50499.6 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.78% during the forecast period.
The North America market for Botanical Drug is estimated to increase from $ 1682.4 million in 2023 to reach $ 2342 million by 2029, at a CAGR of 5.67% during the forecast period of 2024 through 2029.
The China market for Botanical Drug is estimated to increase from $ 22212 million in 2023 to reach $ 28796 million by 2029, at a CAGR of 4.42% during the forecast period of 2024 through 2029.
The Europe market for Botanical Drug is estimated to increase from $ 6650 million in 2023 to reach $ 9229 million by 2029, at a CAGR of 5.61% during the forecast period of 2024 through 2029.
The global key companies of Botanical Drug include: Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Guangzhou Baiyunshan Pharmaceutical, Tasly Holding Group, Jumpcan Pharmaceutical, Yunnan Baiyao, etc. In 2022, the global top five players had a share approximately 19.65 % in terms of revenue.
Report Includes:
This report presents an overview of global market for Botanical Drug market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Botanical Drug, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Botanical Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Botanical Drugrevenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Botanical Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Botanical Drug revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, Yunnan Baiyao, and Tasly Holding Group, etc.
By Company
- Buchang Pharmaceuticals
- China TCM
- Tsumura
- Schwabe
- Tong Ren Tang
- Jumpcan Pharmaceutical
- Guangzhou Baiyunshan
- Yunnan Baiyao
- Tasly Holding Group
- Bionorica Se
- Huarun 999
- Taiji
- Weleda
- Kwangdong
- GW Pharmaceuticals
Segment by Type
Segment by Application
- Cardiovascular
- Tumor
- Respiratory System
- Others
By Region
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Rest of Europe
Chapter Outline
- Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
- Chapter 2: Revenue of Botanical Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
- Chapter 3: Detailed analysis of Botanical Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: North America (North America) by Type, by Application and by country, revenue for each segment.
- Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
- Chapter 8: China by Type, and by Application, revenue for each segment.
- Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
- Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
- Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Botanical Drugrevenue, gross margin, and recent development, etc.
- Chapter 12: Analyst's Viewpoints/Conclusions
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Botanical Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
- 1.2.2 Prescription Drug
- 1.2.3 OTC
- 1.3 Market by Application
- 1.3.1 Global Botanical Drug Market Share by Application: 2018 VS 2022 VS 2029
- 1.3.2 Cardiovascular
- 1.3.3 Tumor
- 1.3.4 Respiratory System
- 1.4 Assumptions and Limitations
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Botanical Drug Market Perspective (2018-2029)
- 2.2 Global Botanical Drug Growth Trends by Region
- 2.2.1 Global Botanical Drug Market Size by Region: 2018 VS 2022 VS 2029
- 2.2.2 Botanical Drug Historic Market Size by Region (2018-2023)
- 2.2.3 Botanical Drug Forecasted Market Size by Region (2024-2029)
- 2.3 Botanical Drug Market Dynamics
- 2.3.1 Botanical Drug Industry Trends
- 2.3.2 Botanical Drug Market Drivers
- 2.3.3 Botanical Drug Market Challenges
- 2.3.4 Botanical Drug Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Revenue Botanical Drug by Players
- 3.1.1 Global Botanical Drug Revenue by Players (2019-2023)
- 3.1.2 Global Botanical Drug Revenue Market Share by Players (2019-2023)
- 3.2 Global Botanical Drug Market by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Global Key Players of Botanical Drug, Ranking by Revenue, 2021 VS 2022
- 3.4 Global Botanical Drug Market Concentration Ratio
- 3.4.1 Global Botanical Drug Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Botanical Drug Revenue in 2022
- 3.5 Global Key Players of Botanical Drug Head office and Area Served
- 3.6 Global Key Players of Botanical Drug, Founded Date
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Botanical Drug Breakdown Data by Type
- 4.1 Global Botanical Drug Historic Market Size by Type (2018-2023)
- 4.2 Global Botanical Drug Forecasted Market Size by Type (2024-2029)
5 Botanical Drug Breakdown Data by Application
- 5.1 Global Botanical Drug Historic Market Size by Application (2018-2023)
- 5.2 Global Botanical Drug Forecasted Market Size by Application (2024-2029)
6 North America
- 6.1 North America Botanical Drug Market Size (2018-2029)
- 6.2 North America Botanical Drug Market Size by Type
- 6.2.1 North America Botanical Drug Market Size by Type (2018-2023)
- 6.2.2 North America Botanical Drug Market Size by Type (2024-2029)
- 6.2.3 North America Botanical Drug Market Share by Type (2018-2029)
- 6.3 North America Botanical Drug Market Size by Application
- 6.3.1 North America Botanical Drug Market Size by Application (2018-2023)
- 6.3.2 North America Botanical Drug Market Size by Application (2024-2029)
- 6.3.3 North America Botanical Drug Market Share by Application (2018-2029)
- 6.4 North America Botanical Drug Market Size by Country
- 6.4.1 North America Botanical Drug Market Size by Country: 2018 VS 2022 VS 2029
- 6.4.2 North America Botanical Drug Market Size by Country (2018-2023)
- 6.4.3 North America Botanical Drug Market Share by Country (2024-2029)
- 6.4.4 United States
- 6.4.5 Canada
7 Europe
- 7.1 Europe Botanical Drug Market Size (2018-2029)
- 7.2 Europe Botanical Drug Market Size by Type
- 7.2.1 Europe Botanical Drug Market Size by Type (2018-2023)
- 7.2.2 Europe Botanical Drug Market Size by Type (2024-2029)
- 7.2.3 Europe Botanical Drug Market Share by Type (2018-2029)
- 7.3 Europe Botanical Drug Market Size by Application
- 7.3.1 Europe Botanical Drug Market Size by Application (2018-2023)
- 7.3.2 Europe Botanical Drug Market Size by Application (2024-2029)
- 7.3.3 Europe Botanical Drug Market Share by Application (2018-2029)
- 7.4 Europe Botanical Drug Market Size by Country
- 7.4.1 Europe Botanical Drug Market Size by Country: 2018 VS 2022 VS 2029
- 7.4.2 Europe Botanical Drug Market Size by Country (2018-2023)
- 7.4.3 Europe Botanical Drug Market Size by Country (2024-2029)
- 7.4.4 Germany
- 7.4.5 France
- 7.4.6 U.K.
- 7.4.7 Italy
- 7.4.8 Russia
8 China
- 8.1 China Botanical Drug Market Size (2018-2029)
- 8.2 China Botanical Drug Market Size by Type
- 8.2.1 China Botanical Drug Market Size by Type (2018-2023)
- 8.2.2 China Botanical Drug Market Size by Type (2024-2029)
- 8.2.3 China Botanical Drug Market Share by Type (2018-2029)
- 8.3 China Botanical Drug Market Size by Application
- 8.3.1 China Botanical Drug Market Size by Application (2018-2023)
- 8.3.2 China Botanical Drug Market Size by Application (2024-2029)
- 8.3.3 China Botanical Drug Market Share by Application (2018-2029)
9 Asia (excluding China)
- 9.1 Asia Botanical Drug Market Size (2018-2029)
- 9.2 Asia Botanical Drug Market Size by Type
- 9.2.1 Asia Botanical Drug Market Size by Type (2018-2023)
- 9.2.2 Asia Botanical Drug Market Size by Type (2024-2029)
- 9.2.3 Asia Botanical Drug Market Share by Type (2018-2029)
- 9.3 Asia Botanical Drug Market Size by Application
- 9.3.1 Asia Botanical Drug Market Size by Application (2018-2023)
- 9.3.2 Asia Botanical Drug Market Size by Application (2024-2029)
- 9.3.3 Asia Botanical Drug Market Share by Application (2018-2029)
- 9.4 Asia Botanical Drug Market Size by Region
- 9.4.1 Asia Botanical Drug Market Size by Region: 2018 VS 2022 VS 2029
- 9.4.2 Asia Botanical Drug Market Size by Region (2018-2023)
- 9.4.3 Asia Botanical Drug Market Size by Region (2024-2029)
- 9.4.4 Japan
- 9.4.5 South Korea
- 9.4.6 Southeast Asia
- 9.4.7 India
- 9.4.8 Australia
10 Middle East, Africa, and Latin America
- 10.1 Middle East, Africa, and Latin America Botanical Drug Market Size (2018-2029)
- 10.2 Middle East, Africa, and Latin America Botanical Drug Market Size by Type
- 10.2.1 Middle East, Africa, and Latin America Botanical Drug Market Size by Type (2018-2023)
- 10.2.2 Middle East, Africa, and Latin America Botanical Drug Market Size by Type (2024-2029)
- 10.2.3 Middle East, Africa, and Latin America Botanical Drug Market Share by Type (2018-2029)
- 10.3 Middle East, Africa, and Latin America Botanical Drug Market Size by Application
- 10.3.1 Middle East, Africa, and Latin America Botanical Drug Market Size by Application (2018-2023)
- 10.3.2 Middle East, Africa, and Latin America Botanical Drug Market Size by Application (2024-2029)
- 10.3.3 Middle East, Africa, and Latin America Botanical Drug Market Share by Application (2018-2029)
- 10.4 Middle East, Africa, and Latin America Botanical Drug Market Size by Country
- 10.4.1 Middle East, Africa, and Latin America Botanical Drug Market Size by Country: 2018 VS 2022 VS 2029
- 10.4.2 Middle East, Africa, and Latin America Botanical Drug Market Size by Country (2018-2023)
- 10.4.3 Middle East, Africa, and Latin America Botanical Drug Market Size by Country (2024-2029)
- 10.4.4 Brazil
- 10.4.5 Mexico
- 10.4.6 Middle East
- 10.4.7 Africa
11 Key Players Profiles
- 11.1 Buchang Pharmaceuticals
- 11.1.1 Buchang Pharmaceuticals Details
- 11.1.2 Buchang Pharmaceuticals Major Business Analysis
- 11.1.3 Buchang Pharmaceuticals Botanical Drug Product and Solutions
- 11.1.4 Buchang Pharmaceuticals Botanical Drug Revenue, Gross Margin and Market Share (2019-2023)
- 11.2 China TCM
- 11.2.1 China TCM Details
- 11.2.2 China TCM Major Business Analysis
- 11.2.3 China TCM Botanical Drug Product and Solutions
- 11.2.4 China TCM Botanical Drug Revenue, Gross Margin and Market Share (2019-2023)
- 11.3 Tsumura
- 11.3.1 Tsumura Details
- 11.3.2 Tsumura Major Business Analysis
- 11.3.3 Tsumura Botanical Drug Product and Solutions
- 11.3.4 Tsumura Botanical Drug Revenue, Gross Margin and Market Share (2019-2023)
- 11.4 Schwabe
- 11.4.1 Schwabe Details
- 11.4.2 Schwabe Major Business Analysis
- 11.4.3 Schwabe Botanical Drug Product and Solutions
- 11.4.4 Schwabe Botanical Drug Revenue, Gross Margin and Market Share (2019-2023)
- 11.5 Tong Ren Tang
- 11.5.1 Tong Ren Tang Details
- 11.5.2 Tong Ren Tang Major Business Analysis
- 11.5.3 Tong Ren Tang Botanical Drug Product and Solutions
- 11.5.4 Tong Ren Tang Botanical Drug Revenue, Gross Margin and Market Share (2019-2023)
- 11.6 Jumpcan Pharmaceutical
- 11.6.1 Jumpcan Pharmaceutical Details
- 11.6.2 Jumpcan Pharmaceutical Major Business Analysis
- 11.6.3 Jumpcan Pharmaceutical Botanical Drug Product and Solutions
- 11.6.4 Jumpcan Pharmaceutical Botanical Drug Revenue, Gross Margin and Market Share (2019-2023)
- 11.7 Guangzhou Baiyunshan Pharmaceutical
- 11.7.1 Guangzhou Baiyunshan Pharmaceutical Details
- 11.7.2 Guangzhou Baiyunshan Pharmaceutical Major Business Analysis
- 11.7.3 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product and Solutions
- 11.7.4 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue, Gross Margin and Market Share (2019-2023)
- 11.8 Yunnan Baiyao
- 11.8.1 Yunnan Baiyao Details
- 11.8.2 Yunnan Baiyao Major Business Analysis
- 11.8.3 Yunnan Baiyao Botanical Drug Product and Solutions
- 11.8.4 Yunnan Baiyao Botanical Drug Revenue, Gross Margin and Market Share (2019-2023)
- 11.9 Tasly Holding Group
- 11.9.1 Tasly Holding Group Details
- 11.9.2 Tasly Holding Group Major Business Analysis
- 11.9.3 Tasly Holding Group Botanical Drug Product and Solutions
- 11.9.4 Tasly Holding Group Botanical Drug Revenue, Gross Margin and Market Share (2019-2023)
- 11.10 Bionorica Se
- 11.10.1 Bionorica Se Details
- 11.10.2 Bionorica Se Major Business Analysis
- 11.10.3 Bionorica Se Botanical Drug Product and Solutions
- 11.10.4 Bionorica Se Botanical Drug Revenue, Gross Margin and Market Share (2019-2023)
- 11.11 Huarun 999
- 11.11.1 Huarun 999 Details
- 11.11.2 Huarun 999 Major Business Analysis
- 11.11.3 Huarun 999 Botanical Drug Product and Solutions
- 11.11.4 Huarun 999 Botanical Drug Revenue, Gross Margin and Market Share (2019-2023)
- 11.12 Taiji
- 11.12.1 Taiji Details
- 11.12.2 Taiji Major Business Analysis
- 11.12.3 Taiji Botanical Drug Product and Solutions
- 11.12.4 Taiji Botanical Drug Revenue, Gross Margin and Market Share (2019-2023)
- 11.13 Weleda
- 11.13.1 Weleda Details
- 11.13.2 Weleda Major Business Analysis
- 11.13.3 Weleda Botanical Drug Product and Solutions
- 11.13.4 Weleda Botanical Drug Revenue, Gross Margin and Market Share (2019-2023)
- 11.14 Kwangdong
- 11.14.1 Kwangdong Details
- 11.14.2 Kwangdong Major Business Analysis
- 11.14.3 Kwangdong Botanical Drug Product and Solutions
- 11.14.4 Kwangdong Botanical Drug Revenue, Gross Margin and Market Share (2019-2023)
- 11.15 GW Pharmaceuticals
- 11.15.1 GW Pharmaceuticals Details
- 11.15.2 GW Pharmaceuticals Major Business Analysis
- 11.15.3 GW Pharmaceuticals Botanical Drug Product and Solutions
- 11.15.4 GW Pharmaceuticals Botanical Drug Revenue, Gross Margin and Market Share (2019-2023)
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Author Details
- 13.3 Disclaimer